Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astera Labs (ALAB) Liabilities and Shareholders Equity (2023 - 2025)

Historic Liabilities and Shareholders Equity for Astera Labs (ALAB) over the last 3 years, with Q3 2025 value amounting to $1.4 billion.

  • Astera Labs' Liabilities and Shareholders Equity rose 4253.2% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 billion, marking a year-over-year increase of 6382.3%. This contributed to the annual value of $1.1 billion for FY2024, which is 43721.39% up from last year.
  • Per Astera Labs' latest filing, its Liabilities and Shareholders Equity stood at $1.4 billion for Q3 2025, which was up 4253.2% from $1.3 billion recorded in Q2 2025.
  • In the past 5 years, Astera Labs' Liabilities and Shareholders Equity ranged from a high of $1.4 billion in Q3 2025 and a low of $196.3 million during Q4 2023
  • For the 3-year period, Astera Labs' Liabilities and Shareholders Equity averaged around $976.1 million, with its median value being $1.0 billion (2024).
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first skyrocketed by 43721.39% in 2024, then skyrocketed by 2969.05% in 2025.
  • Quarter analysis of 3 years shows Astera Labs' Liabilities and Shareholders Equity stood at $196.3 million in 2023, then soared by 437.21% to $1.1 billion in 2024, then surged by 32.88% to $1.4 billion in 2025.
  • Its Liabilities and Shareholders Equity stands at $1.4 billion for Q3 2025, versus $1.3 billion for Q2 2025 and $1.1 billion for Q1 2025.